“…There remains a need to take advantage of the unique features of proximal embolic protection systems (including their potential to completely prevent cerebral ischaemic events) [ 5 , 7 , 9 , 10 ], particularly when treating lesions of increased embolic risk. CAS operators should be cognisant of the fact that the anti-embolic stent cannot be expected to exert any effect until implanted and post-dilated [ 15 ]. Practical knowledge and experience on how to use proximal cerebral protection to reduce intra-procedural embolic complications of CAS is an indispensable element of today’s competent CAS [ 5 , 7 ].…”